| Neuropathology of Parkinson disease |
49 |
| Gut microbiota in patients with Parkinson's disease in southern China |
35 |
| Fecal markers of intestinal inflammation and intestinal permeability are elevated in Parkinson's disease |
26 |
| A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson's disease |
21 |
| The spectrum of off in Parkinson's disease: What have we learned over 40 years? |
20 |
| Dysbiosis of gut microbiota in a selected population of Parkinson's patients |
20 |
| Freezing of gait: Promising avenues for future treatment |
20 |
| Sex differences in progression to mild cognitive impairment and dementia in Parkinson's disease |
19 |
| A meta-analysis: Parkinson's disease and dual-task walking |
19 |
| Helicobacter pylori infection is associated with an increased risk of Parkinson's disease: A population-based retrospective cohort study |
16 |
| Carriers of both GBA and LRRK2 mutations, compared to carriers of either, in Parkinson's disease: Risk estimates and genotype-phenotype correlations |
16 |
| Spinocerebellar ataxia 48 presenting with ataxia associated with cognitive, psychiatric, and extrapyramidal features: A report of two Italian families |
15 |
| STN vs. GPi deep brain stimulation for tremor suppression in Parkinson disease: A systematic review and meta -analysis |
15 |
| Gait characteristics and falls in Parkinson's disease: A systematic review and meta-analysis |
15 |
| Mirabegron in patients with Parkinson disease and overactive bladder symptoms: A retrospective cohort |
14 |
| MR planimetry in neurodegenerative parkinsonism yields high diagnostic accuracy for PSP |
14 |
| The importance of preclinical diagnostics in Parkinson disease |
14 |
| Altered body composition, sarcopenia, frailty, and their clinico-biological correlates, in Parkinson's disease |
14 |
| Integration of technology-based outcome measures in clinical trials of Parkinson and other neurodegenerative diseases |
13 |
| Importance of the initial response to GPi deep brain stimulation in dystonia: A nine year quality of life study |
13 |
| Resting-state fMRI in Parkinson's disease patients with cognitive impairment: A meta-analysis |
13 |
| Reproducibility of data-driven Parkinson's disease subtypes for clinical research |
13 |
| Parkinson's disease phenotype is influenced by the severity of the mutations in the GBA gene |
13 |
| Overview of the cholinergic contribution to gait, balance and falls in Parkinson's disease |
13 |
| Proteomic analysis of tear fluid reveals disease-specific patterns in patients with Parkinson's disease - A pilot study |
13 |
| Dyspnea: An underestimated symptom in Parkinson's disease |
13 |
| Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease |
13 |
| Phenotypic heterogeneity in seven Italian cases of aceruloplasminemia |
13 |
| Neurite orientation dispersion and density imaging of the nigrostriatal pathway in Parkinson's disease: Retrograde degeneration observed by tract-profile analysis |
13 |
| Cortical thinning correlates of changes in visuospatial and visuoperceptual performance in Parkinson's disease: A 4-year follow-up |
12 |
| Simultaneous low-frequency deep brain stimulation of the substantia nigra pars reticulata and high-frequency stimulation of the subthalamic nucleus to treat levodopa unresponsive freezing of gait in Parkinson's disease: A pilot study |
12 |
| Retinal layers in Parkinson's disease: A meta-analysis of spectral-domain optical coherence tomography studies |
12 |
| Orthostatic hypotension in Parkinson disease: Impact on health care utilization |
12 |
| A detailed clinical study of pain in 1957 participants with early/moderate Parkinson's disease |
12 |
| Relationship between the MDS-UPDRS and Quality of Life: A large multicenter study of 3206 patients |
11 |
| Associations between daily-living physical activity and laboratory-based assessments of motor severity in patients with falls and Parkinson's disease |
11 |
| A review of basal ganglia circuits and physiology: Application to deep brain stimulation |
11 |
| New Era in disease modification in Parkinson's disease: Review of genetically targeted therapeutics |
11 |
| Parkinsonism-related beta oscillations in the primate basal ganglia networks Recent advances and clinical implications |
11 |
| Can the gut be the missing piece in uncovering PD pathogenesis? |
11 |
| Whole genome sequencing for the genetic diagnosis of heterogenous dystonia phenotypes |
11 |
| Predictors of health-related quality of life in Parkinson's disease |
11 |
| Directional DBS leads show large deviations from their intended implantation orientation |
11 |
| The overlap between Essential tremor and Parkinson disease |
10 |
| Anosognosia for cognitive and behavioral symptoms in Parkinson's disease with mild dementia and mild cognitive impairment: Frequency and neuropsychological/neuropsychiatric correlates |
10 |
| Conversion to MCI and dementia in Parkinson's disease: a systematic review and meta-analysis |
10 |
| Neuromelanin-sensitive MRI of the substantia nigra: An imaging biomarker to differentiate essential tremor from tremor-dominant Parkinson's disease |
10 |
| The colorful spectrum of Tourette syndrome and its medical, surgical and behavioral therapies |
10 |
| Combinatory microRNA serum signatures as classifiers of Parkinson's disease |
10 |
| Dopamine transporter availability reflects gastrointestinal dysautonomia in early Parkinson disease |
10 |
